Table 3. Pair-wise analysis of phospho-Akt, S6RP, phosphor-4E-BP1 and grading by Cox-regression (disease-free survival).
|   | 
  | 
  | 
95% CI for Exp (B) | 
  | 
|
|---|---|---|---|---|---|
| Factor | Against | Exp | Min | Max | Significance | 
| Phospho-Akt | S6RP | 3.459 | 1.012 | 11.820 | 0.048 | 
| Phospho-4E-BP1 | 2.702 | 0.630 | 11.589 | 0.181 | |
|   | 
Histograding | 
3.439 | 
1.006 | 
11.757 | 
0.049 | 
| S6RP | Phospho-Akt | 4.440 | 0:512 | 38.546 | 0.176 | 
| Phospho-4E-BP1 | 4.235 | 0.490 | 36.589 | 0.190 | |
|   | 
Histograding | 
6.270 | 
0.802 | 
49.025 | 
0.080 | 
| Phospho-4E-BP1 | Phospho-Akt | 4.067 | 1.241 | 13.330 | 0.021 | 
| S6RP | 4.067 | 1.241 | 13.330 | 0.021 | |
|   | 
Histograding | 
4.067 | 
1.241 | 
13.330 | 
0.021 | 
| Histograding | Phospho-Akt | 3.688 | 1.124 | 12.095 | 0.031 | 
| S6RP | 3.688 | 1.124 | 12.095 | 0.031 | |
| Phospho-4E-BP1 | 3.490 | 1.062 | 11.467 | 0.040 | |
Abbreviations: CI=confidence interval; mTOR=mammalian target of rapamycin; S6RP=S6 ribosomal protein.
Parameter phospho-Akt expression lower than 104 RIU versus higher than 104 RIU; S6RP expression lower than 329 RIU versus higher than 329 RIU; phospho-4E-BP1 expression lower than 121 RIU versus higher than 121 RIU; Grading G1 and G2 versus G3. Statistically significant values are depicted in bold italic letters.